British Toxicological Society Annual Congress 2018 – Hilton Gateshead (16th-18th April)

British Toxicological Society Annual Congress 2018

Hilton Gateshead – 16th-18th April

The Newcells Biotech team will be attending the British Toxicological Society Annual Congress 2018 that is taking place in Gateshead on 16th-18th April.  Newcells Biotech staff will be present throughout the Congress and looking forward to engaging with the existing programme of presentations and discussions on topics such as in vitro assays, liver and lung toxicity.  Dr Mike Nicholds, Prof Lyle Armstrong and Dr Colin Brown will be attending along with a number of the Newcells technical team.

Two posters will be presented by Dr Chichagova and Dr Chung on “Using statistical models to identify key variables critical for generation of retinal organoids from iPSC for further use in pharmacological and toxicological studies”  and “Newcells Biotech’s aProximate human primary proximal tubule cell monolayers as a novel predictive model of nephrotoxicity”.

You might also be interested in…

Looking Forward: A Year in Review

2018 has been a significant year for Newcells Biotech. We have secured substantial investment, launched new, ground-breaking products, attended global events and expanded our every growing team.   Here are some of our defining moments


Newcells Head to Boston

International Trade Mission – December 2018  Newcells Biotech CEO, Dr Mike Nicholds, and CSO, Prof Lyle Armstrong, are delighted to be taking part in a global trade mission hosted by the Department for International Trade and partially funded by the Northern Powerhouse. Dr Nicholds and Prof Armstrong will travel to Greater


ESTIV 2018 International Congress

Congress Round-Up The International Congress on in vitro Toxicology (ESTIV2018) organised by the European Society of Toxicology was held in Berlin this October 2018.  This year marks its 20th meeting, with the general theme of new approach methodologies